A detailed history of Great Point Partners LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Great Point Partners LLC holds 2,906,259 shares of URGN stock, worth $35.6 Million. This represents 12.93% of its overall portfolio holdings.

Number of Shares
2,906,259
Previous 2,620,545 10.9%
Holding current value
$35.6 Million
Previous $39.3 Million 24.06%
% of portfolio
12.93%
Previous 9.62%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.72 - $19.2 $3.63 Million - $5.49 Million
285,714 Added 10.9%
2,906,259 $48.8 Million
Q3 2023

Nov 14, 2023

BUY
$8.84 - $22.64 $23.2 Million - $59.3 Million
2,620,545 New
2,620,545 $36.7 Million
Q1 2023

May 15, 2023

SELL
$7.99 - $11.02 $4.16 Million - $5.74 Million
-520,778 Reduced 93.0%
39,222 $362,000
Q4 2022

Feb 14, 2023

SELL
$7.55 - $11.96 $2.37 Million - $3.75 Million
-313,424 Reduced 35.88%
560,000 $4.97 Million
Q4 2021

Feb 14, 2022

BUY
$9.03 - $19.13 $1.11 Million - $2.36 Million
123,424 Added 16.46%
873,424 $8.31 Million
Q3 2021

Nov 15, 2021

BUY
$14.31 - $18.39 $10.7 Million - $13.8 Million
750,000 New
750,000 $12.6 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $278M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.